Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levothyroxine in AUS Goiter
NCT02329379Phase 4Withdrawn
- Start
- May 2015
- Primary completion
- Dec 2015
- Modality
- Small Molecules
01
Overview
Phase 4, open-label trial of levothyroxine sodium in goiter (8 arms). Primary endpoints: Number of participants with reduced goiter volume under sono >15% at 2 years and Number of participants with fine-needle aspiration cytology: benign*2 times at 2 years. Planned start May 2015; status: withdrawn.
02
Drugs
levothyroxine sodium
03
Conditions
goiter
Beyond the preview
Go deeper on NCT02329379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02329379.